Vaccine - China Epidemiology Lead
赛诺菲中国
- 公司规模:5000-10000人
- 公司性质:外资(欧美)
- 公司行业:制药/生物工程
职位信息
- 发布日期:2019-09-20
- 工作地点:北京
- 招聘人数:1人
- 工作经验:无工作经验
- 学历要求:招1人
- 语言要求:不限
- 职位类别:生物工程/生物制药
职位描述
Key responsibilities:
This position is to develop and lead Sanofi Pasteur’s epidemiology and health economics evidence generation strategy to support the company’s vaccine portfolio strategy in order to shape a favorable environment for our existing products and for the launch of new products in China.
The Regional Senior Director, VEM - China will ensure smooth planning and execution of the activities led by the country staff, ensuring strong alignment between the global franchise strategies and the regional/local business opportunities. This high quality research agenda will be built in consultation with the business, key thought leaders and major stakeholder groups such as public health institutions and payers.
He will have a key role in demonstrating the value to the VEM team, translating the research outcomes into sound business opportunities when interfacing with global functions representatives and to bring the voice of the regions into global team meetings.
Key Accountability:
(% of time)
Support the elaboration of the epidemiology and health economics evidence generation strategy across emerging regions in close collaboration with global partners and regional stakeholders (Market Access, Medical Affairs, Public Affairs, Policy and Commercial Operations)
(20%)
Support the use of epidemiological and economic evidence to inform decision-making internally, at Sanofi Pasteur, and externally by our customers, recommending bodies and public health. Bering the voice of the China region in HQ discussions
(20%)
Ensure scientific excellence and strong compliance/integrity for the China region research agenda. Support impactful publications and communication in scientific congresses
(20%)
Develop a network of academic and public health partners that can guide the company’s research agenda, support research execution and thus maximize the company’s ability to generate impactful evidence. Ensure SP is seen as a preferred partner for such public private evidence generation.
(10%)
Oversee and ensure smooth planning and execution of the activities in emerging regions and enhance the use of the generated data to shape a favorable environment
(20%)
Develop individuals reporting to the role
(10%)
职位要求:
Requirements:
Competencies:
-Strong motivation for public health
-Solid international research experience
-Strategic thinking and strong business acumen and market access understanding
-Scientific excellence
-Exceptional written and oral communication skills
-Ability to develop, motivate and lead people
-High level of self-awareness
-Ability to cooperate cross-functionally
-People management experienceEducation/experience:
-PhD in Epidemiology/Public Health/ Health /Economics or focused on quantitative analysis. Preference will be given to individuals with a Medical (MD) or Pharmacy (PharmD) qualification.
-More than 10 years of public health research experience demonstrated with relevant publications record
-Previous experience working on vaccines or infectious diseases and in the emerging markets
-Expertise in developing epidemiological studies
-Fluent in English and Mandarin. Fluency in additional languages will be a bonus.
This position is to develop and lead Sanofi Pasteur’s epidemiology and health economics evidence generation strategy to support the company’s vaccine portfolio strategy in order to shape a favorable environment for our existing products and for the launch of new products in China.
The Regional Senior Director, VEM - China will ensure smooth planning and execution of the activities led by the country staff, ensuring strong alignment between the global franchise strategies and the regional/local business opportunities. This high quality research agenda will be built in consultation with the business, key thought leaders and major stakeholder groups such as public health institutions and payers.
He will have a key role in demonstrating the value to the VEM team, translating the research outcomes into sound business opportunities when interfacing with global functions representatives and to bring the voice of the regions into global team meetings.
Key Accountability:
(% of time)
Support the elaboration of the epidemiology and health economics evidence generation strategy across emerging regions in close collaboration with global partners and regional stakeholders (Market Access, Medical Affairs, Public Affairs, Policy and Commercial Operations)
(20%)
Support the use of epidemiological and economic evidence to inform decision-making internally, at Sanofi Pasteur, and externally by our customers, recommending bodies and public health. Bering the voice of the China region in HQ discussions
(20%)
Ensure scientific excellence and strong compliance/integrity for the China region research agenda. Support impactful publications and communication in scientific congresses
(20%)
Develop a network of academic and public health partners that can guide the company’s research agenda, support research execution and thus maximize the company’s ability to generate impactful evidence. Ensure SP is seen as a preferred partner for such public private evidence generation.
(10%)
Oversee and ensure smooth planning and execution of the activities in emerging regions and enhance the use of the generated data to shape a favorable environment
(20%)
Develop individuals reporting to the role
(10%)
职位要求:
Requirements:
Competencies:
-Strong motivation for public health
-Solid international research experience
-Strategic thinking and strong business acumen and market access understanding
-Scientific excellence
-Exceptional written and oral communication skills
-Ability to develop, motivate and lead people
-High level of self-awareness
-Ability to cooperate cross-functionally
-People management experienceEducation/experience:
-PhD in Epidemiology/Public Health/ Health /Economics or focused on quantitative analysis. Preference will be given to individuals with a Medical (MD) or Pharmacy (PharmD) qualification.
-More than 10 years of public health research experience demonstrated with relevant publications record
-Previous experience working on vaccines or infectious diseases and in the emerging markets
-Expertise in developing epidemiological studies
-Fluent in English and Mandarin. Fluency in additional languages will be a bonus.
职能类别:生物工程/生物制药
公司介绍
赛诺菲集团
赛诺菲集团是一家全球领先的多元化医药健康企业,专注于患者需求,传播健康。
全球100,000余名员工,业务遍及100个国家
新兴市场实力均衡,表现强劲,位列***
多元领域,覆盖处方药、健康药业产品、疫苗和动物保健品
疫苗领域的领导者
领先动物保健市场
2011年集团净销售额达334亿欧元
赛诺菲在中国
赛诺菲是首批在中国开设办事处的跨国制药集团,也是国内增长最快的医药健康企业之一。目前,赛诺菲在中国200多个城市拥有6000余名员工。
传承悠久历史、持续开拓进取
赛诺菲一直以来秉承对中国的承诺。1982年,赛诺菲成为首批在中国开设办事处的跨国制药企业之一。今天,赛诺菲已跻身中国医药健康市场的领军企业。赛诺菲的中国总部位于上海,并在北京、天津、沈阳、济南、上海、杭州、南京、武汉、成都、广州和乌鲁木齐共设11家区域办公室。
独特的医药健康产品系列、满足中国公共卫生需求
从预防到治疗,赛诺菲全方位满足中国的公共健康需求。集团的疫苗事业部赛诺菲巴斯德是中国领先的疫苗企业。赛诺菲在心血管/血栓、糖尿病、肿瘤、内科和中枢神经系统等关键的治疗领域拥有领先产品。2010年,杭州赛诺菲民生健康药业有限公司的成立标志着赛诺菲进入中国的非处方药市场。2011年2月,赛诺菲完成了对BMP太阳石的收购。
大幅投资工业建设、满足中国市场需求
赛诺菲目前在中国拥有六家生产基地,包括北京制药工厂、杭州制药工厂、杭州赛诺菲民生健康药业工厂、南昌梅里亚动物保健工厂、深圳赛诺菲巴斯德疫苗工厂、以及唐山健康药业工厂。
完善的研发架构、双赢的研发合作模式
在中国,赛诺菲具有从药物靶点发现到后期临床研究的整体研发实力。集团在上海设有中国研发中心和亚太研发中心,并在北京和成都分别设有研发机构。自2008年以来,赛诺菲与中国权威科研机构开展了10多项战略合作,在癌症、干细胞、糖尿病和老年疾病等前沿研究领域探索创新药物
依托于强劲的研发能力和多领域领先水平的广泛的医药产品资源,公司在中国的市场份额不断攀升,公司规模不断扩大,飞速发展的业务给了我们与更多优秀人才合作的机会。
如需了解更多信息,请访问*************
现在就行动!把握机遇,加入我们,您的职业生涯将与赛诺菲共同成长!抓住机会,来亲身体验我们所秉持的胆略、创新、团结、勇气的价值观。
请将您的中英文简历发给我们,并在email标题栏注明您所申请的职位名称。每个职位申请一次即可,请不要重复投递简历。谢谢!
赛诺菲集团是一家全球领先的多元化医药健康企业,专注于患者需求,传播健康。
全球100,000余名员工,业务遍及100个国家
新兴市场实力均衡,表现强劲,位列***
多元领域,覆盖处方药、健康药业产品、疫苗和动物保健品
疫苗领域的领导者
领先动物保健市场
2011年集团净销售额达334亿欧元
赛诺菲在中国
赛诺菲是首批在中国开设办事处的跨国制药集团,也是国内增长最快的医药健康企业之一。目前,赛诺菲在中国200多个城市拥有6000余名员工。
传承悠久历史、持续开拓进取
赛诺菲一直以来秉承对中国的承诺。1982年,赛诺菲成为首批在中国开设办事处的跨国制药企业之一。今天,赛诺菲已跻身中国医药健康市场的领军企业。赛诺菲的中国总部位于上海,并在北京、天津、沈阳、济南、上海、杭州、南京、武汉、成都、广州和乌鲁木齐共设11家区域办公室。
独特的医药健康产品系列、满足中国公共卫生需求
从预防到治疗,赛诺菲全方位满足中国的公共健康需求。集团的疫苗事业部赛诺菲巴斯德是中国领先的疫苗企业。赛诺菲在心血管/血栓、糖尿病、肿瘤、内科和中枢神经系统等关键的治疗领域拥有领先产品。2010年,杭州赛诺菲民生健康药业有限公司的成立标志着赛诺菲进入中国的非处方药市场。2011年2月,赛诺菲完成了对BMP太阳石的收购。
大幅投资工业建设、满足中国市场需求
赛诺菲目前在中国拥有六家生产基地,包括北京制药工厂、杭州制药工厂、杭州赛诺菲民生健康药业工厂、南昌梅里亚动物保健工厂、深圳赛诺菲巴斯德疫苗工厂、以及唐山健康药业工厂。
完善的研发架构、双赢的研发合作模式
在中国,赛诺菲具有从药物靶点发现到后期临床研究的整体研发实力。集团在上海设有中国研发中心和亚太研发中心,并在北京和成都分别设有研发机构。自2008年以来,赛诺菲与中国权威科研机构开展了10多项战略合作,在癌症、干细胞、糖尿病和老年疾病等前沿研究领域探索创新药物
依托于强劲的研发能力和多领域领先水平的广泛的医药产品资源,公司在中国的市场份额不断攀升,公司规模不断扩大,飞速发展的业务给了我们与更多优秀人才合作的机会。
如需了解更多信息,请访问*************
现在就行动!把握机遇,加入我们,您的职业生涯将与赛诺菲共同成长!抓住机会,来亲身体验我们所秉持的胆略、创新、团结、勇气的价值观。
请将您的中英文简历发给我们,并在email标题栏注明您所申请的职位名称。每个职位申请一次即可,请不要重复投递简历。谢谢!
联系方式
- 公司地址:地址:span北京